Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTyman Regulatory News (TYMN)

  • This share is currently suspended. It was suspended at a price of 398.00
  • There is currently no data for TYMN

Directorate Changes

31 May 2023 07:00

RNS Number : 0773B
Tyman PLC
31 May 2023
 

31 May 2023

TYMAN PLC

("Tyman" or the "Group")

 

Appointment of Non-executive Director and Chair of the Audit & Risk Committee

Tyman plc, a leading international supplier of engineered fenestration components and access solutions to the construction industry, today announces that Dr Margaret Amos will join the Board as an independent Non-executive Director with effect from 19 June 2023. She will be a member of each of the Remuneration and Nominations Committee and, from 21 July 2023, she will take on the role of Chair of the Audit & Risk Committee.

As a result of Margaret's appointment, and as highlighted by the Group in its Annual Report and Accounts for the financial year ended 31 December 2022, Helen Clatworthy will retire as a Non-executive Director and Chair of the Audit & Risk Committee with effect from 21 July 2023.

Margaret's career began at Rolls-Royce plc in 1990, where she gained extensive financial and commercial experience as Senior Finance Business Partner, Aerospace (from 2013 to 2015) and Finance Director, Corporate, IT and Engineering (from 2015 to 2017). She currently serves as a non-executive director of Volution Group plc (where she is a member of the Audit, Remuneration and Nomination Committees) and Pod Point Group Holdings plc (where she is Chair of its Audit and ESG Committees).

Margaret has also chaired the Audit Committees of Velocity Composites plc, the Southern Derbyshire and Erewash NHS Clinical Commissioning Group, Derbyshire Health United, the Ombudsman Service and Trinity House. She has also served NMCN plc as a Non-executive Director and Chair of its Remuneration Committee.

Margaret is a Fellow of the Chartered Institute of Management Accountants and the Chartered Institute of Procurement and Supply, and she holds a Doctorate in Professional Practice from the University of Derby and a Masters in Global Supply Chain Management (with distinction) from the University of Nottingham.

Nicky Hartery, Chair of the Board and the Nominations Committee, commented:

"We are delighted to welcome Margaret to Tyman's Board and Chair of Tyman's Audit & Risk Committee. We strongly believe that the Group will benefit from her deep and broad expertise across finance, M&A, procurement and ESG."

Enquiries

Tyman plc

020 7976 8000

Jason Ashton - Interim Chief Executive Officer

Juliette Lowes - Interim Chief Financial Officer

Matt Jones - Head of Investor Relations

investor.relations@tymanplc.com

 

MHP

020 3128 8613

Reg Hoare / Rachel Farrington / Matthew Taylor

tyman@mhpgroup.com

Notes to editors

Tyman (TYMN: LSE) is a leading international supplier of engineered fenestration components and access solutions to the construction industry. The company designs and manufactures products that enhance the comfort, sustainability, security, safety and aesthetics of residential homes and commercial buildings. Tyman's portfolio of leading brands serve their markets through three divisions: Tyman North America, Tyman UK & Ireland and Tyman International. Headquartered in London, the Group employs approximately 3,700 people with facilities in 16 countries worldwide. Further information is available at www.tymanplc.com.

· At the date of this announcement, Margaret Amos has no beneficial interests in Tyman's shares.

· In accordance with Listing Rule LR 9.6.13(1) R, Margaret has held the following directorships of publicly quoted companies in the last 5 years:

Company

Still a director

North Midland Construction Company plc

N

Velocity Composites plc

N

Pod Point Group Holdings plc

Y

Volution Group plc

Y

 

· There is no additional information to be disclosed in respect of Margaret Amos pursuant to Listing Rule 9.6.13 (2) to (6) R.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAWPUGWAUPWGQU
Date   Source Headline
23rd Apr 202411:53 amRNSForm 8.3 - Tyman plc
23rd Apr 202411:45 amRNSForm 8.3 - Tyman plc
23rd Apr 202411:41 amPRNForm 8.3 - Tyman plc
23rd Apr 202411:35 amRNSForm 8.5 (EPT/RI) - Tyman Plc
23rd Apr 202411:32 amRNSForm 8.3 -Quanex Building Products Corporation
23rd Apr 202411:29 amRNSForm 8.3 - Tyman plc
23rd Apr 202410:49 amRNSForm 8.5 (EPT/RI) - Tyman Plc
22nd Apr 20242:59 pmRNSForm 8.3 - Quanex Building Products Corporation
22nd Apr 20242:57 pmRNSForm 8.3 - Tyman plc
22nd Apr 202412:01 pmPRNForm 8.3 - Tyman plc
22nd Apr 20247:00 amRNSRecommended Cash and Share Offer
17th Apr 202411:22 amRNSHolding(s) in Company
28th Mar 20247:00 amRNS2023 Annual Report & Notice of AGM
7th Mar 20247:00 amRNSFinal Results
31st Jan 20247:00 amRNSNotice of Results
10th Jan 20248:00 amRNSDirector Declaration
27th Nov 20236:17 pmRNSDirector/PDMR Shareholding
27th Nov 20237:00 amRNSAppointment of new CEO
20th Nov 20232:00 pmRNSHolding(s) in Company
16th Nov 20237:00 amRNSTrading Statement
31st Oct 20237:00 amRNSCapital Markets Event
2nd Oct 20237:00 amRNSNotice of Capital Markets Event
25th Jul 20237:00 amRNSHalf-year Report
12th Jul 20235:00 pmRNSAcquisition of Lawrence Industries
8th Jun 20239:21 amRNSHolding(s) in Company
1st Jun 20237:00 amRNSSBTi approval of carbon reduction targets
31st May 20237:00 amRNSDirectorate Changes
26th May 202310:59 amRNSDirector/PDMR Shareholding
19th May 202310:24 amRNSDirector/PDMR Shareholding
18th May 20231:30 pmRNSResult of AGM
18th May 20237:00 amRNSAGM Trading Update
21st Apr 20237:00 amRNSAppointment of Interim Chief Financial Officer
21st Apr 20237:00 amRNSDirector/PDMR Shareholding
6th Apr 20233:10 pmRNSAGM Update - Withdrawal of AGM Resolution
6th Apr 20237:00 amRNSDirectorate Change
3rd Apr 20237:00 amRNSAnnual Financial Report
30th Mar 20239:10 amRNSDirector/PDMR Shareholding
24th Mar 20231:34 pmRNSHolding(s) in Company
22nd Mar 20234:30 pmRNSDirector/PDMR Shareholding
14th Mar 20234:16 pmRNSDirector/PDMR Shareholding
3rd Mar 20235:00 pmRNSDirector/PDMR Shareholding
2nd Mar 20237:00 amRNSFinal Results
16th Feb 20237:00 amRNSNotice of Results
28th Dec 20223:53 pmRNSHolding(s) in Company
15th Dec 202210:59 amRNSHolding(s) in Company
14th Dec 202212:00 pmRNSRefinancing of Debt Facilities
28th Nov 20223:30 pmRNSHolding(s) in Company
17th Nov 20227:00 amRNSTrading Statement
18th Oct 202212:00 pmRNSHolding(s) in Company
6th Oct 20223:41 pmRNSTR-1 Replacement: Notification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.